Background -Genetic mutations are the most common cause of hypertrophic cardiomyopathy(HCM) and an increasingly recognized cause of dilated cardiomyopathy. Autosomal dominant HCM is caused by mutations in sarcomere pr...Background -Genetic mutations are the most common cause of hypertrophic cardiomyopathy(HCM) and an increasingly recognized cause of dilated cardiomyopathy. Autosomal dominant HCM is caused by mutations in sarcomere proteins; such mutations are not universally present, however, and fail to account for ≈=40%of cases of phenotypic HCM. To add further complexity, other genetic origins can mimic the gross clinical phenotype of HCM, and mutations in sarcomere genes have been demonstrated to cause dilated cardiomyopathy. Methods and Results -To explore novel genetic causes of inherited cardiomyopathies, genome-wide linkage analysis was used to study one kindred(4 generations, 32 individuals) with predominant clinical features of left ventricular hypertrophy in addition to cardiac dilation, end-stage heart failure, and sudden death. Of note, histopathology from 2 family members did not demonstrate myocyte disarray and fibrosis, indicating that this phenotype is not typical sarcomere mutation HCM. Direct DNA sequencing was performed on sarcomere genes known to cause HCM and dilated cardiomyopathy, and no mutations were identified. Linkage was then established to a novel locus on chromosome 7(7p12.1-7q21). A maximum 2-point logarithm of odds score of 4.11 was obtained. Recombination events refine the disease interval between D7S506 and D7S3314, corresponding to a distance of 27.2 megabases. Conclusions -The discovery of a novel genetic locus in this family provides more evidence that molecular pathways leading to inherited cardiac hypertrophy extend beyond the sarcomere. Identification of the causal gene mutation and additional genotype-phenotype correlation studies will provide fundamental insight into mechanisms of cardiac remodeling.展开更多
The aim of this study is to investigate the functional relationship between filamin, a known actin binding protein, and myosin and the effects of filamin on the interaction between myosin and actin. Methods.Ultra cent...The aim of this study is to investigate the functional relationship between filamin, a known actin binding protein, and myosin and the effects of filamin on the interaction between myosin and actin. Methods.Ultra centrifugation method was used to investigate the binding of filamin to both phosphorylated and unphosphorylated myosins. Mg ATPase activities of both phosphorylated and unphosphorylated myosins in the presence and absence of actin were measured to observe the effects resulted from filamin actin and filamin myosin interactions. Results. It was found that filamin is also a myosin binding protein. Filamin inhibited the actin activated Mg ATPase activity of phosphorylated myosin and stimulated Mg ATPase of phosphorylated myosin in the absence of actin; in addition, filamin stimulated Mg ATPase activity of unphosphorylated myosin in both the presence or absence of actin. Conclusion. The results suggest that the effects of filamin on the myosin Mg ATPase activities are bi directional, i.e., stimulatory via binding to myosin and inhibitory via binding to actin.展开更多
肥厚型心肌病(hypertrophic cardiomyopathy,H C M)被证实是引发35岁以下青年人(尤其是运动员)心源性猝死(sudden cardiac death,S C D)的首要原因。约60%的H C M患者由编码肌小节蛋白的基因突变导致,呈常染色体显性遗传模式。P肌球蛋...肥厚型心肌病(hypertrophic cardiomyopathy,H C M)被证实是引发35岁以下青年人(尤其是运动员)心源性猝死(sudden cardiac death,S C D)的首要原因。约60%的H C M患者由编码肌小节蛋白的基因突变导致,呈常染色体显性遗传模式。P肌球蛋白重链基因、肌球蛋白结合蛋白C基因、肌钙蛋白T基因、肌钙蛋白I基因被认为是引起H C M最常见的突变基因。基因检测在H C M的临床诊断中已趋于常态化,但在法医工作中应用较少,如果基因检测技术能够应用于法医病理学诊断,将会给H C M猝死案件的死亡原因确认工作提供便利。更重要的是,通过猝死者的基因检测结果尽早进行家庭成员的危险评估才能降低猝死的发生率。本文主要综述j H C M的分子机制进展以及该疾病在法医病理学诊断中的应用价值。展开更多
文摘Background -Genetic mutations are the most common cause of hypertrophic cardiomyopathy(HCM) and an increasingly recognized cause of dilated cardiomyopathy. Autosomal dominant HCM is caused by mutations in sarcomere proteins; such mutations are not universally present, however, and fail to account for ≈=40%of cases of phenotypic HCM. To add further complexity, other genetic origins can mimic the gross clinical phenotype of HCM, and mutations in sarcomere genes have been demonstrated to cause dilated cardiomyopathy. Methods and Results -To explore novel genetic causes of inherited cardiomyopathies, genome-wide linkage analysis was used to study one kindred(4 generations, 32 individuals) with predominant clinical features of left ventricular hypertrophy in addition to cardiac dilation, end-stage heart failure, and sudden death. Of note, histopathology from 2 family members did not demonstrate myocyte disarray and fibrosis, indicating that this phenotype is not typical sarcomere mutation HCM. Direct DNA sequencing was performed on sarcomere genes known to cause HCM and dilated cardiomyopathy, and no mutations were identified. Linkage was then established to a novel locus on chromosome 7(7p12.1-7q21). A maximum 2-point logarithm of odds score of 4.11 was obtained. Recombination events refine the disease interval between D7S506 and D7S3314, corresponding to a distance of 27.2 megabases. Conclusions -The discovery of a novel genetic locus in this family provides more evidence that molecular pathways leading to inherited cardiac hypertrophy extend beyond the sarcomere. Identification of the causal gene mutation and additional genotype-phenotype correlation studies will provide fundamental insight into mechanisms of cardiac remodeling.
文摘The aim of this study is to investigate the functional relationship between filamin, a known actin binding protein, and myosin and the effects of filamin on the interaction between myosin and actin. Methods.Ultra centrifugation method was used to investigate the binding of filamin to both phosphorylated and unphosphorylated myosins. Mg ATPase activities of both phosphorylated and unphosphorylated myosins in the presence and absence of actin were measured to observe the effects resulted from filamin actin and filamin myosin interactions. Results. It was found that filamin is also a myosin binding protein. Filamin inhibited the actin activated Mg ATPase activity of phosphorylated myosin and stimulated Mg ATPase of phosphorylated myosin in the absence of actin; in addition, filamin stimulated Mg ATPase activity of unphosphorylated myosin in both the presence or absence of actin. Conclusion. The results suggest that the effects of filamin on the myosin Mg ATPase activities are bi directional, i.e., stimulatory via binding to myosin and inhibitory via binding to actin.
文摘肥厚型心肌病(hypertrophic cardiomyopathy,H C M)被证实是引发35岁以下青年人(尤其是运动员)心源性猝死(sudden cardiac death,S C D)的首要原因。约60%的H C M患者由编码肌小节蛋白的基因突变导致,呈常染色体显性遗传模式。P肌球蛋白重链基因、肌球蛋白结合蛋白C基因、肌钙蛋白T基因、肌钙蛋白I基因被认为是引起H C M最常见的突变基因。基因检测在H C M的临床诊断中已趋于常态化,但在法医工作中应用较少,如果基因检测技术能够应用于法医病理学诊断,将会给H C M猝死案件的死亡原因确认工作提供便利。更重要的是,通过猝死者的基因检测结果尽早进行家庭成员的危险评估才能降低猝死的发生率。本文主要综述j H C M的分子机制进展以及该疾病在法医病理学诊断中的应用价值。